share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Havanec Laurie P.

CVS Health | 4: Statement of changes in beneficial ownership of securities

西維斯健康 | 4:持股變動聲明
SEC announcement ·  04/04 05:04
牛牛AI助理已提取核心訊息
On April 1, 2024, Laurie P. Havanec, EVP and Chief People Officer at CVS Health, completed a stock transaction involving the company's common stock. Havanec acquired 9,426 restricted shares at a price of $79.56 per share. On the same day, she disposed of 7,630 shares at the same price, with the total market value of the disposed shares amounting to $607,042.80. Following these transactions, Havanec's direct holdings in CVS Health common stock totaled 9,426 shares.
On April 1, 2024, Laurie P. Havanec, EVP and Chief People Officer at CVS Health, completed a stock transaction involving the company's common stock. Havanec acquired 9,426 restricted shares at a price of $79.56 per share. On the same day, she disposed of 7,630 shares at the same price, with the total market value of the disposed shares amounting to $607,042.80. Following these transactions, Havanec's direct holdings in CVS Health common stock totaled 9,426 shares.
2024年4月1日,CVS Health執行副總裁兼首席人事官勞裏·哈瓦內克完成了一項涉及該公司普通股的股票交易。哈瓦內克以每股79.56美元的價格收購了9,426股限制性股票。同一天,她以相同的價格出售了7,630股股票,處置股票的總市值爲607,042.80美元。這些交易之後,哈瓦內克直接持有的CVS Health普通股共計9,426股。
2024年4月1日,CVS Health執行副總裁兼首席人事官勞裏·哈瓦內克完成了一項涉及該公司普通股的股票交易。哈瓦內克以每股79.56美元的價格收購了9,426股限制性股票。同一天,她以相同的價格出售了7,630股股票,處置股票的總市值爲607,042.80美元。這些交易之後,哈瓦內克直接持有的CVS Health普通股共計9,426股。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。